Macy's is not a strong buy right now for a Beginner long-term investor with $50,000-$100,000 to deploy. The stock has short-term momentum, but the setup is too mixed: price is above key moving averages and MACD is improving, yet RSI is overbought and analyst sentiment is largely cautious with multiple price-target cuts. Since there is no AI Stock Picker or SwingMax buy signal today, the better call is to hold and wait for a clearer long-term entry rather than buy aggressively at this level.
Technically, M is in a bullish short-term trend: SMA_5 > SMA_20 > SMA_200 and the MACD histogram is positive and expanding, which supports continued momentum. However, RSI_6 at 80.47 signals the stock is overbought, so the current pre-market price of 22.45 is near the upper end of the recent range and close to resistance (R1 21.971, R2 23.07). That makes upside limited in the near term and increases the chance of a pause or pullback before a better entry forms.

The option flow is also mildly bullish, and technical momentum remains positive.
UBS is bearish, warning Macy's may keep losing market share due to challenges in price, product, and service, with earnings likely pressured and consensus EPS drifting lower. Multiple firms have cut price targets, including Citi, Telsey, TD Cowen, and JPMorgan. The company is also closing 150 stores through 2026, showing ongoing structural pressure in the retail model. RSI is overbought, so the stock may be extended in the short term.
Latest quarter: Q4 2025. The available analyst commentary says Macy's Q4 results beat expectations and management's execution was strong, with merchandising and marketing improving. However, the company issued below-Street FY26 guidance, and several analysts flagged ongoing pressure from weak sales, macro risk, and opex deleverage. Net, the latest quarter looks better operationally than feared, but the forward growth trend is still not strong enough to support an aggressive long-term buy case.
Analyst sentiment is mixed but leans cautious. Positives: Jefferies has a Buy rating and sees upside as execution-led, and Telsey noted Q4 ahead of guidance with improving momentum. Negatives: UBS remains Sell and argues market share loss and earnings pressure will continue; Citi, TD Cowen, and JPMorgan are Neutral/Hold with lower targets. Overall, Wall Street views Macy's as a turnaround/execution story with limited conviction, not a high-confidence long-term compounder.